{"id":"W4414082877","doi":"10.1016/j.jtho.2025.07.117","title":"Enhanced Versus Standard Dermatologic Management With Amivantamab-Lazertinib in EGFR-Mutated Advanced NSCLC: The COCOON Global Randomized Controlled Trial","year":2025,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Cilag; Chugai Pharmaceutical; Johnson and Johnson; University of California, Irvine; Daiichi Sankyo Europe; Gilead Sciences; LEO Pharma; Genentech; Grifols; GlaxoSmithKline; Orient Europharma; Eli Lilly and Company; Ono Pharmaceutical; Astellas Pharma; G1 Therapeutics; Revolution Medicines; Merck KGaA; BeiGene; Mirati Therapeutics; Sanofi; Amgen; Pfizer; AstraZeneca; Bristol-Myers Squibb","keywords":"Randomized controlled trial; Incidence (geometry); Regimen; MEDLINE; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00119795,0.001081956,0.00184478,0.0002864947,0.0001943363,0.0008321373,0.000636267,0.001087922,0.006981066],"category_scores_gemma":[0.001382925,0.0002949827,0.002164297,0.000330289,0.0005993673,0.00069331,0.0003331034,0.001344912,0.0005018222],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005926574,"about_ca_system_score_gemma":0.000571779,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008815671,"about_ca_topic_score_gemma":0.002128792,"domain_scores_codex":[0.9995537,0.0002512498,0.00002741008,0.0000886686,0.00003023514,0.00004865325],"domain_scores_gemma":[0.999423,0.0001739008,0.0001900881,0.00003714098,0.00004284794,0.0001330038],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9810596,0.001569249,0.0006687309,0.001006084,0.001406492,0.00002615114,0.0000151368,0.0001946984,0.0008986362,0.00007670549,0.0007406711,0.01233778],"study_design_scores_gemma":[0.9589452,0.03448582,0.002972338,0.0001057902,0.00180417,0.00004019213,0.00002102388,0.0005701604,0.0002296245,0.000118814,0.0006953806,0.00001155572],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9755259,0.01425075,0.0005795449,0.00100958,0.0007260611,0.002495144,0.001745062,0.0001535701,0.003514434],"genre_scores_gemma":[0.9885299,0.003214162,0.00103424,0.001202969,0.0004670243,0.002312885,0.001256121,0.00001516315,0.001967623],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006981066,"threshold_uncertainty_score":0.02335399,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01006854121310488,"score_gpt":0.4333679795858871,"score_spread":0.4232994383727823,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}